{"transactions":[{"id":685153,"issuer":{"id":8100,"kind":"organization","name":"IceCure Medical Ltd."},"owners":[{"id":22783,"kind":"person","name":"Good Shad","position":1,"cik":"0002047216","reported_name":"Good Shad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Sales for North America"}}],"security":"Ordinary Shares","published_at":"2026-08-17T12:26:11.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":131483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents (i) 131,483 restricted share units (\"RSUs\") granted on August 14, 2026, 25% of which vest on August 11, 2027, and the remaining 75% vest in twelve equal quarterly installments of 6.25% thereafter, (ii) 219 ordinary shares, (iii) 2,021 RSUs granted on July 2, 2024, 25% of which vested on July 29, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, (iv) 1,757 RSUs granted on November 5, 2025, 25% of which vest on November 5, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, and (v) 1,218 RSUs granted on March 16, 2026, 25% of which vest on March 16, 2027, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter. Except for the 25% tranche of the RSUs granted on July 2, 2024 that vested on July 29, 2026, all of the foregoing RSUs remain unvested as of August 13, 2026. The holdings in clauses (ii) through (v) have been adjusted to reflect the Issuer's 1-for-30 reverse share split."}],"balance_after":136698,"source":{"system":"sec-edgar","filing":"0001213900-26-090515","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584371/000121390026090515/ownership.xml","form_type":"4"}},{"id":685151,"issuer":{"id":8100,"kind":"organization","name":"IceCure Medical Ltd."},"owners":[{"id":22780,"kind":"person","name":"Tel-Tzure Tlalit Bussi","position":1,"cik":"0002040298","reported_name":"Tel-Tzure Tlalit Bussi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, BD & Global Marketing"}}],"security":"Ordinary Shares","published_at":"2026-08-17T12:17:09.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":101483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents (i) 101,483 restricted share units (\"RSUs\") granted on August 14, 2026, 25% of which vest on August 11, 2027, and the remaining 75% vest in twelve equal quarterly installments of 6.25% thereafter, (ii) 653 ordinary shares, (iii) 2,273 RSUs granted on July 2, 2024, 25% of which vested on July 29, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, (iv) 1,733 RSUs granted on November 5, 2025, 25% of which vest on November 5, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, and (v) 1,029 RSUs granted on March 16, 2026, 25% of which vest on March 16, 2027, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter. Except for the 25% tranche of the RSUs granted on July 2, 2024 that vested on July 29, 2026, all of the foregoing RSUs remain unvested as of August 13, 2026. The holdings in clauses (ii) through (v) have been adjusted to reflect the Issuer's 1-for-30 reverse share split."}],"balance_after":106518,"source":{"system":"sec-edgar","filing":"0001213900-26-090510","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584371/000121390026090510/ownership.xml","form_type":"4"}},{"id":685152,"issuer":{"id":8100,"kind":"organization","name":"IceCure Medical Ltd."},"owners":[{"id":22782,"kind":"person","name":"Levav Shay","position":1,"cik":"0002047217","reported_name":"Levav Shay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2026-08-17T12:16:31.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":141483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents (i) 141,483 restricted share units (\"RSUs\") granted on August 14, 2026, 25% of which vest on August 11, 2027, and the remaining 75% vest in twelve equal quarterly installments of 6.25% thereafter, (ii) 2,727 RSUs granted on July 2, 2024, 25% of which vested on July 29, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, (iii) 1,447 RSUs granted on November 5, 2025, 25% of which vest on November 5, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, and (iv) 646 RSUs granted on March 16, 2026, 25% of which vest on March 16, 2027, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter. Except for the 25% tranche of the RSUs granted on July 2, 2024 that vested on July 29, 2026, all of the foregoing RSUs remain unvested as of August 13, 2026. The holdings described in clauses (ii) through (iv) have been adjusted to reflect the Issuer's 1-for-30 reverse share split."}],"balance_after":146303,"source":{"system":"sec-edgar","filing":"0001213900-26-090509","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584371/000121390026090509/ownership.xml","form_type":"4"}},{"id":685150,"issuer":{"id":8100,"kind":"organization","name":"IceCure Medical Ltd."},"owners":[{"id":22779,"kind":"person","name":"Dotan Merav Nir","position":1,"cik":"0002048789","reported_name":"Dotan Merav Nir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Ordinary Shares","published_at":"2026-08-17T12:16:02.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":73890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents (i) 73,890 restricted share units (\"RSUs\") granted on August 14, 2026, 25% of which vest on August 11, 2027, and the remaining 75% vest in twelve equal quarterly installments of 6.25% thereafter, (ii) 17 ordinary shares, (iii) 758 RSUs granted on July 2, 2024, 25% of which vested on July 29, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, (iv) 1,080 RSUs granted on November 5, 2025, 25% of which vest on November 5, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, and (v) 440 RSUs granted on March 16, 2026, 25% of which vest on March 16, 2027, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter. Except for the 25% tranche of the RSUs granted on July 2, 2024 that vested on July 29, 2026, all of the foregoing RSUs remain unvested as of August 13, 2026. The holdings described in clauses (ii) through (v) have been adjusted to reflect the Issuer's 1-for-30 reverse share split."}],"balance_after":76168,"source":{"system":"sec-edgar","filing":"0001213900-26-090508","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584371/000121390026090508/ownership.xml","form_type":"4"}},{"id":685149,"issuer":{"id":8100,"kind":"organization","name":"IceCure Medical Ltd."},"owners":[{"id":22778,"kind":"person","name":"Peleg Meir","position":1,"cik":"0002131274","reported_name":"Peleg Meir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-08-17T12:15:38.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":181483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents (i) 181,483 restricted share units (\"RSUs\") granted on August 14, 2026, 25% of which vest on August 11, 2027, and the remaining 75% vest in twelve equal quarterly installments of 6.25% thereafter, and (ii) 13,333 RSUs granted on May 17, 2026, 25% of which vest on May 17, 2027, and the remaining 75% vest in twelve equal quarterly installments of 6.25% thereafter. All of the foregoing RSUs remain unvested as of August 13, 2026. The holdings described in clause (ii) has been adjusted to reflect the Issuer's 1-for-30 reverse share split effected on June 4, 2026."}],"balance_after":194816,"source":{"system":"sec-edgar","filing":"0001213900-26-090507","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584371/000121390026090507/ownership.xml","form_type":"4"}}]}